Correlation Between Intel and Cannara Biotech

Can any of the company-specific risk be diversified away by investing in both Intel and Cannara Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Intel and Cannara Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Intel and Cannara Biotech, you can compare the effects of market volatilities on Intel and Cannara Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Intel with a short position of Cannara Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Intel and Cannara Biotech.

Diversification Opportunities for Intel and Cannara Biotech

-0.65

Correlation Coefficient

Intel  Cannara Biotech

Excellent diversification

The 3 months correlation between Intel and Cannara is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Intel and Cannara Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannara Biotech and Intel is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Intel are associated (or correlated) with Cannara Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannara Biotech has no effect on the direction of Intel i.e., Intel and Cannara Biotech go up and down completely randomly.

Pair Corralation between Intel and Cannara Biotech

Given the investment horizon of 90 days Intel is expected to generate 18.12 times less return on investment than Cannara Biotech. But when comparing it to its historical volatility, Intel is 1.55 times less risky than Cannara Biotech. It trades about 0.0 of its potential returns per unit of risk. Cannara Biotech is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  70.00  in Cannara Biotech on September 4, 2024 and sell it today you would lose (11.00) from holding Cannara Biotech or give up 15.71% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Intel  vs.  Cannara Biotech

Intel

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Intel are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent basic indicators, Intel exhibited solid returns over the last few months and may actually be approaching a breakup point.

Cannara Biotech

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Cannara Biotech are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, Cannara Biotech reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Intel and Cannara Biotech

The main advantage of trading using opposite Intel and Cannara Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Intel position performs unexpectedly, Cannara Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannara Biotech will offset losses from the drop in Cannara Biotech's long position.

The idea behind Intel and Cannara Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.